Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 9 Sep - 04Th Newspaper Advertisement informing Shareholders about re-opening of Special Window for Re-lodgement of transfer requests of physical shares.
Source: Bse
Oriental Aromatics Limited (OAL)
Small CapIndustrials stocks · Small cap · NSE
Oriental Aromatics Limited operates in Aromatics, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.
Data qualityFresh enough for analysisQuote updated 21 Oct, 03:31 pm ISTDetails
Quote21 Oct, 03:31 pm IST
Base fundamentals06 Oct 2026 · screener
Latest result30 Jul, 10:37 pm IST
Score21 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags03 May 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Industrials P/E 26.2 (n=537)
Technical timing lens
Trend score and candlestick chart
69Bullishfull bull SMA stack · SMA20 +12.9% / mo · MACD + · near 52W high
Stock trend: 85
Sector RS: 46
Sector 3M: -7.1% vs Nifty 500 -5.6%
Industrials FPI tailwindNot confirmed
Latest mapped FPI equity flow was not positive. View sector evidence
Technical chart
OALD candles · FIT view+90.8%Latest close ₹604.50 on 2026-10-21
Bar
-1.2%
RSI
68
MACD hist
6.72
52W pos
92%
2026-10-21O ₹612.00H ₹639.00L ₹593.35C ₹604.50Vol 1.7L sh
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context
Relative performance and chart statistics
Adjusted completed-session prices, rebased to 100
OALNifty India ManufacturingNifty 500
- OAL
- +73.7%
- Nifty 500
- -6.5%
- Nifty India Manufacturing
- -7.7%
- Vs Nifty 500
- +80.2 pp
Chart stats
21 Oct 2026- From 52W high
- -5.4%
- 52W range position
- 92%
- ATR (14)
- 5.8%
- Volume vs 20D
- 0.67x
- Avg traded value
- ₹15 Cr
- 20D price channel
- ₹495.4 - ₹639
₹639
₹228 - ₹639
₹35.2
Latest completed session
20-session average
57.4% annualized volatility
Research snapshot
What the evidence says now
Weak fundamentals, while price trend supports entry. This looks more like momentum/speculation than a clean fundamental investment setup.
Weak U-Score but strong trend: momentum may be ahead of fundamentals.
Suggested next step
Momentum only
Trend is strong but fundamentals do not support a clean investment thesis.
U-Score
Legacy · OVERVALUED16
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Latest result
Good67
Revenue +15.2% · PAT +402.0% YoY
Technical
Bullish69
Price trend and sector-relative-strength timing.
Valuation
Legacy model-48025.3%
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Trust
Limited evidence62
Financial-only signal; management claim evidence is not sufficient yet.
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Latest result
Quarter ended 30 Jun 2026
Good · 67/100Rev +15% YoY · PAT +402% YoY · operating leverage · margin compression
Filed 30 Jul 2026
Open results browser →| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹259.8 Cr | +15.2% | -8.0% |
| EBITDA | ₹19.8 Cr | +9.6% | +1.7% |
| Operating margin | 7.6% | -39 bps | +73 bps |
| PAT | ₹2.5 Cr | +402.0% | -37.1% |
| PAT margin | 1.0% | +75 bps | -44 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Fundamentals
Valuation
- P/E
- 326.00
- P/B
- 2.61
- EV/EBITDA
- 21.16
- Market Cap
- 1734.00Cr
Profitability
- ROE
- 0.50%
- ROCE
- 4.47%
- ROA
- 0.42%
- Dividend Y
- 0.10%
Growth (CAGR)
- Revenue 5Y
- 8.00%
- EPS 5Y
- -50.00%
- Revenue 3Y
- 6.00%
- EPS 3Y
- -45.00%
Balance Sheet
- Debt/Equity
- 0.61
- Interest Coverage
- 2.00×
- Altman Z
- 4.01
- Book Value
- 197.00
Cash Flow
- FCF Yield
- —
- FCF Positive Y
- 2/5
- OCF
- 2.00 Cr
- EPS TTM
- 1.59
Shareholding
- Promoter Hold
- 74.17%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 83%
Financial History
Updated 21/10/2026
Revenue
₹ CrLatest: 260-8.0% vs prev
Net Profit
₹ CrLatest: 2.5-37.1% vs prev
ROE is shown only in the Annual view — quarterly equity data isn't published.
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Daily technical trend read
Bullish setupTrend is constructive — long-term uptrend intact. RSI 68.
- Price > SMA20 > SMA50 > SMA200 — full bullish stack.
- SMA20 rising (~11.4% over last month) — short-term momentum positive.
- RSI(14) at 68 — rising, no extreme reading.
- MACD above signal, histogram expanding — bullish momentum building.
- 5% off 52W high · 165% above 52W low.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Nifty 500 leadership
Relative Strength & Trend Stage
95
RS percentile
Stage 2 UptrendEstablished S2
1M return
+10.1%
3M return
+73.7%
6M return
+96.0%
1Y return
+70.1%
RS 1D
0
RS 20D
+1
Sector rank
#2
Industry rank
#6
Stage evidence
- Price is 62.7% above the 30-week proxy.
- The 50-DMA is above the 30-week proxy and its slope is rising +11.6%.
- Both 3-month and 6-month returns are positive.
50-DMA
price above
200-DMA
price above
S2 entered
09 Jul 2026
S2 age
72 trading sessions
Sector
leading
Industry
leading
Relative-strength line vs Nifty 500 (base 100)
262 observations
21 Oct 2026Value 192.76-2.28%
RS vs Nifty 500193
Valuation & peers
U-Score 16 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
Valuation & peers
U-Score 16 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
OVERVALUED
Fundamental score breakdown
U band · OVERVALUEDValuation0/30
Growth4/25
Quality0/20
Balance Sheet7/15
Cash Flow2/10
Piotroski
5/9 (+3)
Penalties
0
Raw sum
16
Why this score?
Top U-Score contributors and drags from the latest stored fundamentals.
16/100 · legacy band OVERVALUED
Positive drivers
- Balance sheet contributes 7/15 to the score.
- Cash flow contributes 2/10 to the score.
- Growth contributes 4/25 to the score.
Main drags
- Fair-value margin of safety is negative at -48025.3%.
- Valuation is weaker at 0/30; verify the latest quarterly trend.
- Quality is weaker at 0/20; verify the latest quarterly trend.
Sector valuation model
Blended valuation: PE, EV/EBITDA, FCF yield, and balance-sheet checks
For this sector, IndiaPulse uses a blended lens rather than relying on a single valuation ratio.
Primary lens
PE, EV/EBITDA, margin of safety, and FCF yield together.
Secondary checks
ROE/ROCE, growth, cash conversion, leverage, promoter risk.
Main risk check
One cheap metric is not enough if quality or cash flow is weak.
PE
326.0
PB
2.6
EV/EBITDA
21.2
ROE
0.5%
ROCE
4.5%
FCF Yield
—
Debt/Equity
0.6
MoS
-48025.3%
Score movement
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Stored run: 21 Oct 2026
v4.3-runtime-valuation
Final score
16
Previous: 16
Legacy U-Score band
OVERVALUED
Previous: OVERVALUED
Margin of safety
-48025.3%
Previous: -49608.9%
Score history
12 stored score snapshots. Latest stored move: +0 points.
21 Oct 2026
v4.3-runtime-valuation
16
16
16
16
16
16
16
16
16
16
16
16
Factor attribution
No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.
Modelled fair value
Graham Number
₹83.95
-620.1% MoS
Growth-justified P/E
0.8
Growth-justified Value
₹1.26
-48025.3% MoS
PEG
—
Comparable companies
Peers
Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
GEMAROMA
Small
Gem Aromatics Limited
Specialty Chemicals
match 158
23
29.0
7.0%
-185%
OVERVALUED
IGPL
Small
IG Petrochemicals Limited
Specialty Chemicals
match 139
30
20.9
0.2%
-3623%
OVERVALUED
BHAGERIA
Small
Bhageria Industries Limited
Specialty Chemicals
match 138
28
23.0
7.0%
-421%
OVERVALUED
SHK
Small
S H Kelkar and Company Limited
Specialty Chemicals
match 138
31
40.3
3.7%
-707%
OVERVALUED
PAUSHAKLTD
Small
Paushak Limited
Specialty Chemicals
match 138
24
43.1
7.0%
-419%
OVERVALUED
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business and thesis
Issuer presentation review pending
Oriental Aromatics Limited operates in Aromatics, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 30 Jun 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.
Trust Score
62Limited evidence · low confidenceTrust Lite
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 35th percentile of the scored universe and 32nd percentile within Industrials. Main check: financial discipline is weak at 40/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Computed 05 Sept 2026
management-trust-v1
150 docs text-extracted · 51 concalls text-extracted
Score band
Limited evidence
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
Relative rank
35th percentile
overall median 67 · Industrials: 32nd pctile, median 68 · Small: 40th pctile, median 66
Evidence depth
Financial-only
150 documents have extracted text, but claim history is not strong enough yet.
Claim delivery
Outcome history still building
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Limited evidence · low confidenceWhat it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Acceptable, but check the weakest sub-score before increasing exposure.
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Promoter
86
strong · holding, pledge, alignment
Cash flow
55
watch · profit to cash conversion
Balance sheet
73
acceptable · leverage and solvency
Discipline
40
weak · capital discipline
Results
53
watch · quarterly consistency
Trust positives
- ▸Promoter holding is 74.2%.
- ▸Promoter pledge is zero.
- ▸4/4 latest quarters had positive YoY revenue growth.
Trust risks
- ▸2 latest quarters had PAT decline worse than 25% YoY.
- ▸ROCE is low at 4.5%.
- ▸ROE is low at 0.5%.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Continue researching Oriental Aromatics Limited
Important announcements & filings
Latest exchange and company disclosures found within the past two years.
Open source ↗
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 10 Jul - 3Rd Newspaper Advertisement informing Shareholders about the re-opening of Special Window for Re-lodgement of transfer requests of physical share
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 30 Jun - Public Notice to Shareholders intimating details of 54th AGM of the Company.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 21 May - Submission of Newspaper publication of Audited Standalone and Consolidated Financial Results
Source: Bse
Annual report
Annual Report 2026
Source: Bse
Annual report
Annual Report 2026 from bse
Source: Bse
Annual report
Annual Report 2025
Source: Bse
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.